A3P Biomedical
Monika Scuka is a seasoned professional in quality assurance and research and development, currently serving as QA Manager at A3P Biomedical since December 2021. Previous experience includes roles as QA Engineer at Medicago AB and Research & Development Senior Scientist at Cavidi, where Monika was involved in ELISA test development, system integration project management, and quality validations. Earlier positions at GE Healthcare Uppsala and Phadia encompassed responsibilities such as complaint investigations, root cause analyses, and both system verification and product design validation. Monika holds a BSc in Chemistry and Biotechnology from Uppsala University and possesses extensive expertise in quality systems, research methodologies, and technical support across various biochemical and immunochemical domains.
This person is not in any teams
This person is not in any offices
A3P Biomedical
1 followers
A3P Biomedical provides prostate cancer diagnosis and treatment. They specialize in advanced prostate cancer diagnostics. Their main product, Stockholm3, is a clinically and commercially validated blood test for the early detection of aggressive prostate cancer. The test combines protein markers, genetic markers, and clinical data in a proprietaryalgorithm for the purpose of detecting aggressive prostate cancer at an early stage.